CRISPR/Cas9-Mediated Gene Correction to Understand ALS.

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron death.
• ALS has a complex genetic basis, with mutations in genes like SOD1, C9orf72, FUS, and TARDBP implicated in familial and sporadic cases.

Purpose of the Study:

• To review the application of CRISPR/Cas9 technology in understanding the genetic underpinnings of ALS.
• To highlight how CRISPR/Cas9 aids in verifying mutation effects and investigating ALS pathophysiology.

Main Methods:

• Utilizing CRISPR/Cas9 for genome editing in animal models and patient-derived induced pluripotent stem cells (iPSCs).
• Correcting known ALS-associated mutations to observe phenotypic changes.
• Introducing specific mutations to study their role in ALS development.

Main Results:

• CRISPR/Cas9 has been instrumental in verifying the pathogenic effects of ALS-associated mutations.
• Gene correction in iPSCs allows for the observation of phenotypic differences compared to patient-derived cells.
• CRISPR/Cas9 facilitates the creation of precise mutations for detailed pathophysiology studies.

Conclusions:

• CRISPR/Cas9 is a powerful tool for dissecting the genetic basis of ALS.
• This technology accelerates research into ALS genetics and potential therapeutic strategies.
• Understanding the genetic landscape of ALS through genome editing is crucial for future treatments.